RESMED INC — Director's Dealing 2019

Aug 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-08-05

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-05	ResMed Common Stock	M	4367	$52.02	Acquired	122250	Direct
2019-08-05	ResMed Common Stock	S	4367	$128.56	Disposed	117883	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-05	ResMed Common Stock Options	$52.02	M	4367	Disposed	2021-11-19	ResMed Commmon Stock (4367)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Represents date options first became exercisable. Options vest 1/3 per year.